Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Apollomics Inc. (APLM : NSDQ)

• Company Description    Apollomics Inc. is a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers. Apollomics Inc., formerly known as Maxpro Capital Acquisition Corp., is based in FOSTER CITY, Calif. Number of Employees: 13

• Price / Volume Information    Yesterday's Closing Price: $5.70 Daily Weekly Monthly 20 Day Moving Average: 26,534 shares Shares Outstanding: 1.10 (millions) Market Capitalization: $6.29 (millions) Beta: 0.93 52 Week High: $28.90 52 Week Low: $4.47 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -17.63% -20.72% 12 Week -4.20% -19.42% Year To Date -41.54% -45.25%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 989 EAST HILLSDALE BLVD. STE 220 - FOSTER CITY,CA 94404 USA ph: 650-209-4055 fax: 650-288-1674 eric@lifesciadvisors.com http://www.apollomicsinc.com

• General Corporate Information    Officers Guo-Liang Yu - Chairman and Chief Executive Officer Matthew Plunkett - Chief Financial Officer and Principal Financial Of Kenneth C. Carter - Director Sanjeev Redkar - Director Glenn S. Vraniak - Director Peer Information Apollomics Inc. (CORR.) Apollomics Inc. (RSPI) Apollomics Inc. (CGXP) Apollomics Inc. (BGEN) Apollomics Inc. (GTBP) Apollomics Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G0411D123 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 1.10 Most Recent Split Date: 11.00 (0.01:1) Beta: 0.93 Market Capitalization: $6.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.27 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.39 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.39 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -3,599.66 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 4.48 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00

Powered by Zacks Investment Research ©